Global Health — 360° view

Global Health, a company in the Hospital industry, reported revenue of ₹1,469 crore and net profit of ₹219 crore for the September 2026 quarter.

Global Health (NSE: MEDANTA) closed at ₹1,480.20 on 20 Nov 2026, up 22.0% over the past year. Its market capitalisation is ₹39,799 crore and it trades at 61.5 times earnings.

Share price
₹1,480.20 (20 Nov 2026)
Market cap
₹39,799 Cr (20 Nov 2026)
P/E
61.47 (20 Nov 2026)
Revenue
₹1,469 Cr (September 2026 quarter)
Net profit
₹219 Cr (September 2026 quarter)
ROCE
17.4% (FY26)
ROE
15.2% (FY26)
Book value
₹161 (FY26)
Dividend yield
0.03% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,544.00 / ₹956.00 (20 Nov 2026)
1-year return
22.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: MEDANTA

Global Health Limited operates a network of multi-specialty tertiary and quaternary care hospitals under the Medanta brand, primarily across North and East India. The company specialises in cardiac sciences, oncology, neurosciences, digestive and hepatobiliary sciences, orthopaedics, organ transplantation, kidney and urology, and other complex medical procedures. As of June 2026, Medanta operated six hospitals across Gurugram, Lucknow, Patna, Ranchi, Indore and Noida, supported by an expanding diagnostics, pharmacy and outpatient network.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.